SCHEMBL4355559

SCHEMBL4355559

O=C1N=C(N2CCN(c3ccccc3)CC2)S/C1=C\c1cc2ccccc2c2ccccc12

nearest known ligand 0.65

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SENP1 Q9P0U3 1/20 0.65
MAPT P10636 8/20 0.60
ALDH1A1 P00352 4/20 0.60
L3MBTL1 Q9Y468 3/20 0.60
HPGD P15428 3/20 0.60
DCTPP1 Q9H773 1/20 0.59
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
POLB P06746 2/20 0.58
KDM4E B2RXH2 1/20 0.52
HTT P42858 1/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
NPC1 O15118 2/20 0.50
RAB9A P51151 1/20 0.50
GRIN1 Q05586 2/20 0.48
GRIN2B Q13224 2/20 0.48
AMY1A P0DUB6 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4355562 1.00 SENP1 (0.65) SENP1MAPTALDH1A1L3MBTL1HPGD
SCHEMBL4350529 0.89 MAPT (0.60) SENP1MAPTALDH1A1HPGDMEN1
SCHEMBL4350532 0.89 MAPT (0.60) SENP1MAPTALDH1A1HPGDMEN1
SCHEMBL4351281 0.86 SENP1 (0.71) SENP1MAPTALDH1A1L3MBTL1HPGD
SCHEMBL4351282 0.86 SENP1 (0.71) SENP1MAPTALDH1A1L3MBTL1HPGD
SCHEMBL3406357 0.79 SENP1 (1.00) SENP1MAPTALDH1A1L3MBTL1HPGD
SCHEMBL4342222 0.79 SENP1 (1.00) SENP1MAPTALDH1A1L3MBTL1HPGD
SCHEMBL4350375 0.76 SENP1 (0.70) SENP1MAPTALDH1A1L3MBTL1HPGD
SCHEMBL4351057 0.76 SENP1 (0.70) SENP1MAPTALDH1A1L3MBTL1HPGD
SCHEMBL4351562 0.76 DCTPP1 (0.63) SENP1MAPTALDH1A1L3MBTL1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US claimed
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP disclosed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs ABCB1, ABCG2, SLC5A2 SENP1 4466/4885MAPT 1470/4885ALDH1A1 284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.